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PKCe Overexpression, Irrespective of Genetic
Background, Sensitizes Skin to UVR-Induced
Development of Squamous-Cell Carcinomas
Jordan M. Sand1,3, Moammir H. Aziz1, Nancy E. Dreckschmidt1, Thomas C. Havighurst2, KyungMann Kim2,
Terry D. Oberley3 and Ajit K. Verma1,3
Chronic exposure to UVR is the major etiologic factor in the development of human skin cancers including
squamous-cell carcinoma (SCC). We have previously shown that protein Kinase C epsilon (PKCe) transgenic
mice on FVB/N background, which overexpress PKCe protein approximately eightfold over endogenous levels
in epidermis, exhibit about threefold more sensitivity than wild-type littermates to UVR-induced development
of SCC. To determine whether it is PKCe and not the mouse genetic background that determines susceptibility
to UVR carcinogenesis, we cross-bred PKCe FVB/N transgenic mice with SKH-1 hairless mice to generate
PKCe-overexpressing SKH-1 hairless mice. To evaluate the susceptibility of PKCe SKH-1 hairless transgenic
mice to UVR carcinogenesis, the mice were exposed to UVR (1–2KJm2) three times weekly from a bank of
six kodacel-filtered FS40 sunlamps. As compared with the wild-type hairless mice, PKCe overexpression in
SKH-1 hairless mice decreased the latency (12 weeks), whereas it increased the incidence (twofold) and
multiplicity (fourfold) of SCC. The SKH hairless transgenic mice were observed to be as sensitive as FVB/N
transgenic mice to UVR-induced development of SCC and expression of proliferative markers (proliferating cell
nuclear antigen, signal transducers and activators of transcription 3, and extracellular signal-regulated kinase 1/
2). The results indicate that PKCe level dictates susceptibility, irrespective of genetic background, to UVR
carcinogenesis.
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INTRODUCTION
Skin cancer accounts for half of all cancers diagnosed in the
United States totaling over 1 million new cases every year
(American Cancer Society, 2009). Squamous-cell carcinoma
(SCC) and basal-cell carcinoma are the most common forms of
nonmelaoma skin cancer. SCC is the most aggressive form of
nonmelanoma skin cancer and, unlike basal-cell carcinoma,
can metastasize (Goldman, 1998).
The most important risk factor for the development of
nonmelanoma skin cancer is chronic exposure to UVR in
sunlight (Cooper and Bowden, 2007; Molho-Pessach and
Lotem, 2007). The UV spectrum, part of the electromagnetic
spectrum, lies between visible light and X-rays and is divided
conventionally into three categories: UVA (315–400 nm),
UVB (280–315 nm), and UVC (190–280nm). Because strato-
spheric ozone absorbs most of the radiation below 310 nm,
UVA and UVB components of sunlight are the most
prominent and ubiquitous carcinogenic electromagnetic
wavelengths in our natural environment (Wheeler et al.,
2004).
UVR is a complete carcinogen, which both initiates and
promotes carcinogenesis. UVB initiates photocarcinogenesis
by directly damaging DNA (de Gruijl and Rebel, 2008;
Marrot and Meunier, 2008; Rass and Reichrath, 2008;
Timares et al., 2008). UVB-induced photoproducts include
cyclobutane pyrimidine dimer, pyrimidine (6-4) pyrimidone
dimer ([6-4]PD), and Dewar photoisomer of the (6-4)PD
(Moriwaki and Takahashi, 2008). The cyclobutane pyrimi-
dine dimer is the predominant photoproduct, accounting for
85% of the primary DNA lesions in UV-irradiated DNA (de
Gruijl et al., 2001). The majority of the DNA lesions are
removed by the nucleotide excision repair (de Gruijl et al.,
2001; Moriwaki and Takahashi, 2008). However, upon DNA
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replication, some cells acquire transition mutations (C-T)
and tandem double mutations (CC-TT) arising at dipyrimi-
dine sites (Brash et al., 1991; Berton et al., 1997). These
mutations are frequently observed in UV-induced SCC in
mice and humans (de Gruijl and Rebel, 2008). Among a
series of gene mutations (TP53, PITCH, and oncogenes) that
are associated with UV-induced skin cancer, C-T and CC-
TT point mutations in the p53 gene are most frequent (Ziegler
et al., 1994; Kanjilal et al., 1995). UVR can induce several
types of epidermal injury including sunburn cell (apoptotic
cell) formation (Ziegler et al., 1994; Kanjilal et al., 1995). The
sunburn cells can be initiated by UV-induced DNA damage
and subsequent induction of p53 protein. The p53-dependent
apoptosis of UV-damaged normal cells (sunburn cells) is
prevented due to p53 mutation. Thus, these mutated cells can
clonally expand to form SCC following subsequent UVR
exposures.
The tumor promotion component of UVR carcinogenesis,
which involves clonal expansion of the initiated cells, is
probably mediated by aberrant expression of genes altered
during tumor initiation. UVR has been reported to alter the
expression of genes regulating inflammation, cell growth and
differentiation, and oncogenesis. Specific examples include
upregulation of the expression of p21 (WAF1/C1P1) (Lu et al.,
1999), p53 (Ziegler et al., 1994), AP-1 activation (Cooper
and Bowden, 2007), ODC (Wheeler et al., 2004), COX2
(Isoherranen et al., 1999), tumor necrosis factor-a, and a wide
variety of cytokines and growth factors (Wheeler et al., 2004).
UVR-induced initial signals linked to the development of skin
cancer are not defined. We found that protein Kinase C
epsilon (PKCe) overexpression in epidermal cells of FVB/N
mice sensitizes the skin to UVR-induced cutaneous damage
and development of SCC.
Protein Kinase C (PKC), a family of phospholipid-
dependent serine/threonine kinases, is not only the major
intracellular receptor for the mouse skin tumor promoter
12-O-tetradecanoylphorbol-13-acetate (TPA) (Mellor and
Parker, 1998; Mochly-Rosen and Kauvar, 1998; Newton,
2001; Angel et al., 2003; Griner and Kazanietz, 2007) but is
also activated by a variety of stress factors including UVR
(Mellor and Parker, 1998; Mochly-Rosen and Kauvar, 1998;
Wheeler et al., 2004). PKCe is among six isoforms (a, d, e, Z,
m, z) expressed in the mouse skin (Mochly-Rosen and Kauvar,
1998). To determine the in vivo functional specificity of PKCe
in mouse skin carcinogenesis, we generated PKCe transgenic
mouse (FVB/N) lines 224 and 215 that overexpress approxi-
mately 8- and 18-fold, respectively, PKCe protein over
endogenous levels in basal epidermal cells (Reddig et al.,
2000; Jansen et al., 2001a, b). PKCe transgenic mice were
observed to be highly sensitive to the development of SCC
elicited by the DMBA (7, 12-Dimethylbenz[a]anthracene)
(100 nmol) – TPA (5 nmol) tumor promotion protocol (Reddig
et al., 2000; Jansen et al., 2001a, b). UVR exposure (1 kJm2
thrice weekly) induced irreparable skin damage in high
PKCe-overexpressing mouse line 215. However, the PKCe
transgenic mouse, line 224, when exposed to UVR (2 kJm2
thrice weekly), exhibited minimum cutaneous damage but
increased SCC multiplicity by threefold and decreased tumor
latency by 12 weeks (Wheeler et al., 2004). However, it is
unknown whether mouse genetic background contributes to
the susceptibility of PKCe transgenic mice to UVR-induced
development of SCC.
In this communication, we cross-bred PKCe FVB/N
transgenic mice with SKH-1 hairless mice to generate
PKCe-overexpressing SKH-1 hairless mice to determine
whether PKCe not mouse genetic background, determines
susceptibility to UVR carcinogenesis. We present that PKCe-
overexpressing SKH-1 hairless mice are as sensitive as their
FVB/N transgenic mice to UVR carcinogenesis.
RESULTS
Generation of PKCe SKH-1 transgenic hairless mice
We have previously reported that PKCe transgenic FVB/N
mice, which overexpress PKCe in the basal epidermal cells
and the cells of the hair follicle, are highly sensitive to UVR-
induced development of SCC (Wheeler et al., 2004). In this
study, we generated PKCe transgenic SKH-1 hairless mice to
determine whether the mouse background contributes to the
sensitivity of PKCe transgenic mice to UVR-induced carcino-
genesis. In this experiment (Figure 1), heterozygous (þ /)
inbred FVB/N K14-T7PKCe mice were crossed for four
generations to wild-type (/) outcrossed SKH1 hairless
mice for transmission of the transgene and hairlessness. Four
generations of crossing were sufficient as SKH-1 is an
outcrossed line, so genetic homogeneity within the mice is
not necessary. PKCe transgenic SKH-1 hairless mice were
phenotypically normal (Figure 1a). Histological examination
of skin of untreated transgenic mice and wild-type mice
revealed no histological differences (Figure 1b). To determine
epidermal PKCe expression level in transgenic and their wild-
type mice, dorsal skin of untreated PKCe SKH-1 transgenic
hairless mice and their wild-type littermates was excised and
fixed in 10% formalin for the analysis of PKCe (Figure 1c).
The dorsal skin of PKCe transgenic mice exhibited signifi-
cantly more immunoreactivity throughout the epidermis
compared with the wild-type dorsal skin with strong staining
in the basal cells. The wild-type dorsal skin sample exhibited
light immunoreactivity to the anti-PKCe antibody throughout
the epidermis (Figure 1c).
The possibility was explored that PKCe may cross-talk to
other PKC isoforms by modulating their levels and their
associated signals. In this experiment (Figure 1d and e), we
determined the levels of other PKC isoforms in the epidermis
of PKCe transgenic SKH-1 hairless mice to examine whether
the elevated PKCe levels in the epidermis altered the level of
expression of other PKC isoforms. As compared with wild-
type SKH-1 hairless mice, PKCe transgenic SKH-1 hairless
mice elicited about eightfold increase in PKCe expression
level. However, there was no change in other PKC isoform
expression levels between wild-type and transgenic mice
(Figure 1d and e).
Susceptibility of SKH-1 PKCe transgenic mice to UVR-induced
development of SCC
The PKCe transgenic SKH-1 hairless mice and their wild-type
littermates (male and female) were treated three times
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(Monday, Wednesday, and Friday) weekly with 2 kJm2
UVR. After 7 weeks of UVR exposure, SKH-1 PKCe transgenic
mice had severe cutaneous damage resulting in blistering,
peeling, sloughing of the skin and the UVR dose was reduced
to 1 kJm2 for the remainder of the study. PKCe over-
expression in SKH-1 hairless mice reduced the latency for
SCC (Figure 2). The first carcinoma in PKCe transgenic SKH-1
hairless male and female mice appeared after 9 and 15 weeks
of UVR exposure, respectively, as compared with 20 and
17 weeks in wild-type male and female littermates, respectively.
Carcinoma multiplicity in male PKCe transgenic mice was
1.18 after 23 weeks of exposure, compared with 1.0 in wild-
type mice. Female PKCe transgenic mice had a carcinoma
multiplicity of 2.57 compared with 1.6 in wild-type mice.
Statistical analysis for determining the difference in multi-
plicities from male and female mice using a Poisson model
for genotype and sex found that males had a P-value of 0.04,
whereas females had a P-value of 0.007. Carcinoma
incidence in male PKCe SKH-1 transgenic and wild-type
mice was 57.8 and 33.3%, respectively (Figure 2b).
Papilloma burden in male transgenic and wild-type mice
was 1.0 and 2.0, respectively. Carcinoma incidence in
female PKCe transgenic and wild-type mice was 53.8 and
20.0%, respectively (Figure 2c). Papilloma burden in female
transgenic and wild-type mice was 1.0 and 2.6, respectively.
Carcinoma incidence was first analyzed for statistical
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Figure 1. Generation of K14-T7PKCe transgenic mice on SKH-1 background. Heterozygous (þ /) FVB/N K14-T7PKCe mice were crossed for four generations
to wild-type (/) outcrossed SKH-1 hairless mice for transmission of the transgene and hairlessness. (a) Phenotype of female SKH-1K14-T7PKCe
transgenic mice. Shown are the photographs of adult SKH-1 hairless PKCe transgenic mouse and its wild-type littermate at 11 weeks of age. (b) Skin histology.
The dorsal skin from a wild-type and PKCe SKH-1 hairless transgenic mouse was fixed in 10% neutral-buffered formalin and embedded in paraffin, and sections
(4 mm) were stained with hematoxylin and eosin. (c) Immunohistochemical staining for PKCe expression, scale bars¼ 50 mm. (d) Epidermal PKC isoform
expression profiles in PKCe SKH-1 hairless transgenic mice and their wild-type littermates; results representative of three replicates. (e) The quantification of
proteins (normalized to b-actin) was performed by densitometry analysis using Total Lab Nonlinear Dynamics Image Analysis Software (Nonlinear USA Inc.).
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significance using the Cox proportional hazards model with
P-values for male mice being P¼0.13 and female mice
P¼0.007. There was no significant gender difference with
either the Poisson model (P¼ 0.86) or Cox proportional
hazards model (P¼ 0.46). Transgenic mice are clearly more
sensitive than wild-type littermates to UVR-induced carcino-
genesis. This sensitivity led to a massive decrease (B3
months) in latency and a significant increase in multiplicity.
Overexpression of PKCe in mouse epidermis increases
sensitivity of skin to UVR-mediated phosphorylation of Stat3,
ERK1/2, and PI3K
The effects of epidermal PKCe overexpression in SKH-1
hairless mice on UVR-induced activation of cell survival
pathways (phosphatidylinositol-3-kinase (PI3K), mitogen-
activated protein kinase (MAPK), and signal transducers and
activators of transcription 3 (Stat3)) were determined. In this
experiment (Figure 3), female PKCe transgenic SKH-1 hairless
mice and their wild-type littermates were exposed to a single
UVR (2 kJm2) dose. Mice were killed at 1, 3, and 6 hours
post-UVR treatment. In wild-type mice, UVR treatment
elicited rapid and transient increase in the expression level
of PI3K (p110), PI3K (p85), phosphorylated extracellular
signal-regulated kinase (ERK) 1/2 (Figure 3a and c), and
phosphorylated Stat3 at both Tyr705 and Ser727 (Figure 3b
and d). However, UVR treatment in PKCe transgenic SKH-1
hairless mice led to persistent activation of Stat3 phosphory-
lation at both Tyr705 and Ser727 (Figure 3b and d), and
phosphorylated ERK1/2 and PI3K (Figure 3a and c).
SCC developed in PKCe transgenic SKH-1 hairless mice elicit
elevated nuclear localization of PCNA and Stat3
In this experiment (Figure 4), SCC from PKCe transgenic
SKH-1 hairless mice and their wild-type littermates (Figure 2)
were excised and fixed in 10% neutral buffered formalin.
Sections of SCC from PKCe transgenic SKH-1 hairless mice
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Figure 2. Susceptibility of PKCe transgenic SKH-1 hairless mice to the
development of SCC by UVR. Male and female PKCe transgenic and wild-
type mice at 11 weeks of age, mice were exposed to UVR (1–2 kJm2) three
times weekly from a bank of six Kodacel-filtered FS40 sunlamps. There were
15 mice per group. Carcinomas were recorded as downward invading lesions,
which were confirmed histologically. The carcinoma data are expressed as
the percentage of effectual total. Carcinoma incidence was analyzed using
Cox proportional hazards model. (a) Representative photograph of a wild-type
and PKCe transgenic SKH-1 mouse after 20 weeks of UVR exposure.
(b) Similarity between FVB/N PKCe line 224 and SKH-1 PKCe line 224,
comparison of decrease in carcinoma latency, increase in carcinoma
multiplicity and PKCe overexpression. (c) Comparison of male wild-type and
PKCe transgenic mice carcinoma incidence. Carcinoma incidence in male
mice was not found to be statistically different, P¼ 0.13. (d) Comparison of
female wild-type and PKCe transgenic mice carcinoma incidence. Carcinoma
incidence in female mice was found to be statistically different P¼0.007.
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Figure 3. UVR-induced phosphorylation of PI3K, ERK1/2, and Stat3 in PKCe
SKH-1 hairless transgenic mice and their wild-type littermates. Female PKCe
transgenic SKH-1 hairless mice (TG) and their wild-type littermates (WT)
(three mice per group) were exposed to a single UVR dose (1 kJm2). The
mice were killed at 1, 3, and 6 hours post-UVR exposure. The mouse
epidermis was scraped off and total lysate was prepared. Total epidermal
lysate from three mice was pooled for the western blot analysis. (a and b) The
epidermal lysate (25 mg protein) was subjected to SDS-PAGE followed by
immunoblot analysis using indicated antibodies. Equal loading was confirmed
by stripping and reprobing the blots with b-actin antibody. (c and d) The
quantification of proteins (normalized to b-actin) was performed by
densitometry analysis using Total Lab Nonlinear Dynamics Image Analysis
Software (Nonlinear USA Inc.).
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and their wild-type littermates were processed for immuno-
histochemistry of PKCe, Stat3, and proliferating cell nuclear
antigen (PCNA) (Figure 4b). SCC from PKCe SKH-1 transgenic
mice showed a significant increase in PKCe, nuclear PCNA
(Figure 4c) and nuclear Stat3 (Figure 4d) staining compared
with wild-type mice (*Po0.05).
DISCUSSION
The PKCe transgenic FVB/N mice, which overexpress PKCe
protein eightfold over endogenous levels in basal epidermal
cells and cells of the hair follicle, are threefold more sensitive
than wildtype to the development of SCC by repeated
exposures to UVR (Wheeler et al., 2004). To determine
whether it is PKCe and not the mouse genetic background
that determines susceptibility to UVR carcinogenesis, we
cross-bred PKCe FVB/N transgenic mice with SKH-1 hairless
mice to generate PKCe-overexpressing SKH-1 hairless mice.
We now present that PKCe-overexpressing SKH-1 hairless
mice are as sensitive as FVB/N PKCe transgenic mice to UVR-
induced development of SCC (Figure 2b).
Genetic differences in susceptibility to two-stage skin
carcinogenesis have been shown to be at the level of tumor
promotion by TPA (Angel et al., 2003). PKCe is among the
major intracellular receptor for the mouse skin tumor
promoter TPA (Mellor and Parker, 1998; Griner and
Kazanietz, 2007) and is activated by a variety of stress factors
including UVR (Wheeler et al., 2004). Furthermore, genetic
mouse background has been shown to be a major determi-
nant of conversion of benign papillomas to malignant SCC
(Woodworth et al., 2004). FVB/N mice are moderately
susceptible to papilloma formation but are highly prone to
undergo malignant conversion (Reddig et al., 2000). PKCe
overexpression in SKH-1 hairless mice, similar to FVB/N
mice, suppressed papilloma formation but enhanced SCC
development. Although, confirmation should await further
experimentation involving crosses with inbred mouse strains
(BALB/c, C57BL/6), the results presented imply that PKCe
appears to be a highly penetrant susceptible gene.
We have previously reported generation and sensitivity of
PKCe transgenic FVB/N mouse lines to UVR (Wheeler et al.,
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Figure 4. Immunohistochemistry of PKCe, Stat3, and PCNA in SCC. PKCe transgenic hairless mice (TG) and their wild-type littermates (WT) were exposed
to UVR, as described in the legend to Figure 2 until the development of SCC. SCC was excised promptly after euthanasia, placed immediately in 10%
neutral-buffered formalin, fixed for 1 hour in formalin, then transferred to phosphate-buffered saline (pH 7.4) and embedded in paraffin. Section of 4mm
thickness was cut for hematoxylin and eosin staining and immunohistochemical study. Each value is the mean±SE from an average of 10 fields from three
different mice was used to calculate Student’s t-test. (a) Hematoxylin and eosin staining (scale bar¼50 mm) (b) Immunoreactivity of PKCe (scale bar¼ 50 mm),
Stat3 (scale bar¼50 mm), and PCNA (scale bar¼ 25 mm). (c and d) Quantification of Stat3 and PCNA nuclear staining. Student’s t-test were performed to analyze
nuclear staining differences (*Po0.05).
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2004). PKCe transgenic line 215, which overexpresses about
18-fold PKCe protein over endogenous levels, elicited severe
cutaneous damage after exposure to UVR (Wheeler et al.,
2004). UVR-induced skin damage in PKCe transgenic line
215 after exposure to UVR (either 1 or 2 kJm2) was
extensive and irreparable, and the experiment could not be
continued until the appearance of carcinomas. However, the
lower PKCe-overexpressing mice (line 224) tolerated three
times weekly UVR exposures (2 kJm2) for 38 weeks and,
had threefold increased SCC multiplicity as well as decreased
tumor latency by 12 weeks when compared with wildtype.
PKCe overexpression in SKH-1 yielded similar results upon
repeated UVR exposure.
The UVR-induced activated PKCe mediates two potential
signals, which lead to inhibition of apoptosis and increased
proliferation of preneoplastic cells. In this context, it is
noteworthy that UVR-induced percentage of sunburn cells
in PKCe transgenic mice was significantly lower than wild-
type littermates (Wheeler et al., 2004). PKCe transgenic
mice were more sensitive than their wild-type littermates to
UVR-induced epidermal proliferation markers PCNA, or-
nithine decarboxylase, and constitutively activated Stat3
(Jansen et al., 2001a, b; Wheeler et al., 2004; Aziz et al.,
2007). Consistent with our previous report, PKCe SKH-1
transgenic mice elicited constitutive activation of Stat3 in
both response to acute UVR exposure and in SCC developed
during chronic UVR exposure. SCC from PKCe transgenic
SKH-1 mice also had increased expression of nuclear PCNA
(Figure 4).
The PI3K/AKT and MAPK pathways are involved in the
regulation of survival pathways in tumor cells. Both PI3K/
AKT and MAPK are activated during UVR carcinogenesis
(Einspahr et al., 2008). However, the mechanism by which
UVR treatment mediates activation of survival pathways
(PI3K/AKT and MAPK) is unclear. PKCe overexpression in
SKH-1 hairless mice accompanied increased expression
of phosphorylated PI3K and MAPK (ERK1/2) implying that
PKCe may impart sensitivity to UVR carcinogenesis through
cross-talk to PI3K and MAPK pathways.
The UVR treatment resulted in increased expression of
PKCe (Figure 3b). This UVR-increased PKCe expression may
be the result of the effect of UVR treatment on PKCe
synthesis. It is noteworthy that PKCe levels are constant
during chronic UVR treatment (data not shown) and in SCC
developed by UVR treatment (Figure 4). These results
(Figure 4) are in contrast to our previous findings with SCC
developed in PKCe mice by DMBA-TPA protocol (Reddig
et al., 2000). A possible explanation for this difference in
PKCe expression level in SCC may be explained by a
difference in antigen retrieval protocol for immunhistochem-
ical localization.
In summary, PKCe-overexpressing SKH-1 hairless
mice, similar to FVB/N, are more sensitive than their wild-
type littermates to induction of SCC by UVR treatment.
UVR-induced activated PKCe cross-talks with survival
pathways (PI3K, MAPK) and regulates constitutive activa-
tion of Stat3, critical factor involved in UVR carcino-
genesis (Kim et al., 2009). PKCe transgenic SKH-1 hairless
mice may provide a useful model to investigate UVR
carcinogenesis.
MATERIALS AND METHODS
Antibodies
The antibodies and sources of the antibodies used in this study were
as follows: PKCe, Stat3, phosphorylated Stat3Tyr705 (pStat3Tyr705),
PI3K (p85), PI3K (p110), b-actin from Santa Cruz Biotechnology
(Santa Cruz, CA); and phosphorylated Stat3Ser727 (pStat3Ser727;
BD Biosciences, San Jose, CA). Blocking peptides for PKCe and Stat3
were obtained from Santa Cruz Biotechnology.
The generation of K14-T7PKCe transgenic mice on SKH-1
background
Transgenic mice-overexpressing T7 epitope-tagged PKC-e (T7-PKCe),
under the control of the human keratin 14 (K14) promoter, using the
inbred FVB/N background were created as described previously
(Reddig et al., 2000). Heterozygous (þ /) inbred FVB/N K14-
T7PKCe mice were crossed for four generations to wild-type (/)
outcrossed SKH1 hairless mice from Charles River Laboratories
(Wilmington, MA) for transmission of the transgene and hairlessness.
Four generations of crossing were sufficient as SKH-1 is an
outcrossed line, so genetic homogeneity within the mice is not
necessary. SKH-1 mice were maintained as an outcrossed line. Thus,
the difference between two ‘‘pure’’ SKH-1 mice is as much as the
difference between a ‘‘pure’’ SKH-1 and a SKH-1//FVB/N cross. All
animal experiments were performed in accordance with approval
from IACUC at the University of Wisconsin-Madison.
UVR treatment of mice
Mice were housed in groups of two to three in plastic bottom cages
in light-, humidity-, and temperature-controlled rooms; food and
water were available ad libitum. The animals were kept in a normal
rhythm of 12-hours-light and 12-hours-dark periods. The UVR
source was Kodacel-filtered FS-40 sunlamps (approximately 60%
UVB and 40% UVA). UVR dose was measured weekly using UVX
radiometer. Mice were used for experimentation at 11–14 weeks of
age. Mice were exposed to UVR (1–2 kJm2) three times weekly
(Monday, Wednesday, and Friday). Tumor multiplicity was observed
weekly and mouse weight was determined every other week.
Carcinomas were recorded grossly as downward-invading lesions,
which were confirmed histologically.
Histologic analysis
Mouse skin was excised promptly after euthanasia and immediately
placed in 10% neutral-buffered formalin, fixed for 24 hours in
formalin, transferred to phosphate-buffered saline (pH 7.4) and then
embedded in paraffin. Four-mm sections were cut for hematoxyli-
n–eosin staining and immunohistochemical study.
Immunohistochemistry of PKCe, Stat3, and PCNA
The PKCe transgenic mice and their wild-type littermates were
exposed to UVR (1–2 kJm2) three times weekly (Monday, Wednes-
day, and Friday), for 26 weeks. SCC specimens were fixed in 10%
neutral-buffered formalin for 24 hours and embedded in paraffin.
Four-mm-thick sections were cut for staining. Briefly, slides were first
treated for antigen retrieval by incubating first in 1 M citric acid (pH
6.0) at 951C for 20minutes and in 0.1 M Tris-EDTA (pH 8.0) for
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20minutes. The slides were washed with phosphate-buffered saline
with 0.5% Tween and incubated overnight at 41C with the primary
antibody. Subsequent incubation steps were performed in a moist
chamber at room temperature. After intermediate washing steps in
Tris-buffered saline (pH 7.4), the sections were incubated with
biotin-labeled rabbit antimouse IgG for 15minutes at room
temperature and then with streptavidin-peroxidase complexes for
15minutes at room temperature. Visualization was performed using
diaminobenzidine as a substrate for the peroxidase reaction. Slides
were transferred into tap water and counterstained with hematoxylin
for 4minutes. Every experiment included a control that contained no
primary antibody but preimmune rabbit serum. Antibody specificity
was observed using blocking peptides. No immunoreactivity was
observed using these controls. Specimens were analyzed using an
Olympus BX 51 microscope (Lake Success, NY).
For quantitation of PCNA and Stat3-positive staining cells,
10 random fields were selected for each mouse. The number of
cells demonstrating positive labeling and the total number of cells
counted were recorded. An average percentage was then calculated
based on the total number of cells and the number of positive
staining cells from each set of 10 fields counted. Results are
expressed as mean of percentages±SE.
Western blot analysis
Mouse skin was excised and scraped to remove subcutaneous fat.
The epidermis was scraped off on a ice-cold glass plate,
homogenized in the lysis buffer (50mmol l1 HEPES, 150mmol l1
NaCl, 10% glycerol, 1% Triton X-100, 1.5mmol l1 MgCl2,
10 mgml1 aprotinin, 10 mgml1 leupeptin, 1mmol l1 phenyl-
methylsulfonyl fluoride, 200 mmol l1 Na3VO4, 200mmol l
1 NaF,
and 1mmol l1 EGTA (final pH 7.5)). The homogenate
was centrifuged at 14,000 g for 30minutes at 41C. Twenty
micrograms of cell lysate were fractionated on 10% Criterion
precast SDS-PAGE (Bio-Rad Laboratories, Hercules, CA). The
protein was transferred to 0.45 mm Hybond-P polyvinylidene
difluoride transfer membrane (Amersham Life Sciences, Piscata-
way, NJ). The membrane was then incubated with the indicated
antibody followed by a horseradish peroxidase secondary antibody
(Santa Cruz Biotechnology), and the detection signal was developed
with Amersham’s enhanced chemiluminescence reagent and auto-
radiography using BioMax film (Kodak, Memphis, TN). The western
blots were quantitated by densitometric analysis using Totallab
Nonlinear Dynamic Image analysis software (Nonlinear USA Inc.,
Durham, NC).
Statistical methods
The primary end point of interest was carcinoma. Those mice that
did not develop carcinoma were censored at the last point at
which data were available for them. Differences in time to event, by
gender and genotype and the interaction of gender and genotype,
were examined visually using Kaplan–Meier method and tested with
Cox proportional hazards models. Also of interest was tumor
multiplicity. Differences in tumor multiplicity by gender, genotype,
and interaction were tested with Poisson regression models.
Computations were performed with R software. (R Development
Core Team, 2007). Student’s t-test was also performed for the
comparison of wildtype and transgenic nuclear localization of Stat3
and PCNA.
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